CIK 0001994702 · <br>Emerging growth company
Kyverna Therapeutics, Inc.
Sign in to watch- Ticker
- KYTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831365441
- Phone
- 5109252492
- Business address
- 5980 HORTON STREET, SUITE 200, EMERYVILLE, CA
- Former names
- Kyverna Therapeutics, Inc.
- 8-K Event Results of operations
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 144 Insider Sale of Securities
- EFFECT Other Notice of Effectiveness
- 424B5 Offering Prospectus
- 144 Insider Sale of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
Page 2 of 10 · 189 filings